Document is current
Any future updates will be listed below
-
Authors
Feu-Basilio, Silvia
Maloca, Peter M.
Hasler, Pascal
Scholl, Hendrik P. N.
Marin-Martinez, Sara
Rosinés-Fonoll, Josep
Suarez-Valero, Xavier
Reich, Michael
Lange, Clemens
Egan, Catherine
Zweifel, Sandrine
Tufail, Adnan
Spaide, Richard F.
Zarranz-Ventura, Javier
-
Funding
Funding for this research was provided by:
This study has been funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. (PI21/01384, PI: Javier Zarranz-Ventura)
- License Information
-
More Information
Article History
Received: 12 November 2023
Accepted: 25 January 2024
First Online: 1 February 2024
Competing interests
: Peter Maloca has been a consultant for Zeiss Forum. He is consultant for Roche, Bayer, Mediconsult, VisionAI (Switzerland), Heidelberg Engineering (Germany), and Bayer (UK). Peter Maloca holds patents for speckle denoising and machine learning. Catherine Egan and Adnan Tufail received a financial grant from the National Institute for Health Research (NIHR) Biomedical Research Centre, Moorfields Eye Hospital; NHS Foundation Trust; and UCL Institute of Ophthalmology. Adnan Tufail is employed as a consultant for Heidelberg Engineering and Optovue. The funding organizations had no role in the design or conduct of this study. Richard Spaide is a consultant for Topcon and Heidelberg. Richard Spaide holds the patent for Frangi vessel segmentation. Outside of this work and without any influence on the conduct or submission of this study, Javier Zarranz-Ventura has been a consultant from Alcon, Alimera Science, Allergan, Bausch & Lomb, Bayer, Brill Pharma, DORC, Novartis, and Roche; is a grant holder in Allergan and Novartis; and has been a lecturer for Topcon and Zeiss. The other authors of this paper declare no competing interests.
